A predictive diagnostic that scores your behavioral health practice across 10 dimensions on a 300-to-850 scale. Built from observed deal outcomes across hundreds of buyer and seller transactions. Forward-looking by design, built to predict where diligence will land.
Each dimension is weighted by its observed impact on deal outcomes in behavioral health transactions. The weighting methodology is proprietary. Flip any card to see what's at stake.
Revenue trends, margin stability, EBITDA normalization, and add-back defensibility. The foundation every buyer's model starts with.
Recurring vs. episodic revenue, billing accuracy, collections velocity, and denial rates. Buyers distinguish between revenue you earn and revenue you defend.
Concentration across Medicaid, commercial, and self-pay. In behavioral health, payor mix is the single most common reason deals collapse or re-trade.
Clinician tenure, credentialing status, turnover rates, and recruitment pipeline. Licensed staff are the product in behavioral health.
Program structure, outcomes measurement, treatment protocols, and documentation standards. Buyers underwrite clinical quality as operating risk.
State licenses, accreditations (CARF, Joint Commission), Stark/AKS exposure, and audit history. The single fastest way to kill a deal at the LOI stage.
Owner dependence, management depth, key-person risk, and operational documentation. The less a practice depends on you, the more it's worth.
EHR maturity, data infrastructure, reporting capabilities, and interoperability. Increasingly a differentiator as buyers seek data-driven platforms.
Census trends, pipeline visibility, geographic expansion potential, and service line development. Buyers pay for where you're going, not just where you are.
Competitive landscape, referral network density, brand recognition, and geographic coverage. Local market leadership drives sustainable valuation premiums.
Your composite score places you in one of five bands. Each band has a distinct implication for your timeline, your leverage, and your outcome at close.
Significant gaps that would result in deal failure or severe re-trade. Not market-ready. Advisory engagement recommended before any buyer conversations.
Identifiable gaps with a clear remediation path. 12 to 24 months of structured preparation to reach transaction-ready status.
Approaching market readiness. Specific gaps remain but are addressable within a 90-day sprint. QofE coordination recommended.
Transaction qualified. Practice is defensible in diligence. Ready for a sell-side engagement with a curated BH-specialist bank.
Top-tier positioning. Practice commands premium multiples and competitive buyer interest. Strongest negotiating leverage at close.
Begin with the free assessment. Go deeper with the full report when you're ready. Both are confidential.
Preliminary scoring across key risk dimensions. No financial data required. Results delivered with context and next-step guidance. Available online, takes approximately 10 minutes.
Complete 10-dimension scoring with written report, strategic roadmap, and 60-minute advisor debrief focused on your highest-impact gaps. Fee is credited toward any program engagement.
The only behavioral health exit diagnostic built by M&A practitioners. 10 dimensions. 300-to-850 scale. Predictive, not retrospective.